Veralto Investing Cash Flow decreased by 1154.3% to -$439.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3890.9%, from -$11.00M to -$439.00M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows relatively stable performance with a 0.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$24.25M | -$24.25M | -$24.25M | -$12.00M | -$9.00M | -$10.00M | -$14.00M | -$22.00M | -$23.00M | -$11.00M | -$6.00M | -$394.00M | -$11.00M | -$40.00M | -$12.00M | -$35.00M | -$439.00M |
| QoQ Change | — | +0.0% | +0.0% | +50.5% | +25.0% | -11.1% | -40.0% | -57.1% | -4.5% | +52.2% | +45.5% | <-999% | +97.2% | -263.6% | +70.0% | -191.7% | <-999% |
| YoY Change | — | — | — | +50.5% | — | — | — | -83.3% | -155.6% | -10.0% | +57.1% | <-999% | +52.2% | -263.6% | -100.0% | +91.1% | <-999% |